CXCL8 and ovarian carcinoma: MIF, as one of the biomarkers for early detection of ovarian cancer, combined with CA125, OPN and anti-IL-8 autoantibody can increase the detection rate of early ovarian cancer to 82%, which significantly improves the detection rate of early ovarian cancer (107).